Microbot Medical Inc. Income Statement
MBOT|5 years of annual SEC 10-K data (FY2011-FY2015)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 5 fiscal years. All figures from audited SEC 10-K filings.
Microbot Medical Inc. reported $172,297 in revenue and $26M in net loss for FY2015. Revenue has declined at a 35.5% compound annual rate over the past 4 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -2.00 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|
| Revenue | $172.3K | $24.0K | $1.2M | $1.4M | $992.9K |
| Cost of Revenue | - | - | $214.8K | $168.4K | $261.4K |
| Gross Profit | - | - | $1.0M | $1.3M | $731.4K |
| SG&A Expense | $8.8M | $7.4M | $8.2M | $9.4M | $9.5M |
| R&D Expense | $19.4M | $14.7M | $19.9M | $21.0M | $19.9M |
| Operating Income | -$28.1M | -$21.9M | -$28.1M | -$29.4M | -$29.4M |
| Interest Expense | $1.2M | $50.2K | $71.4K | $93.4K | $110.8K |
| Net Income | -$26.4M | -$28.5M | -$21.3M | -$25.2M | -$27.0M |
| EPS (Diluted) | -$0.61 | -$0.99 | -$1.50 | -$2.05 | -$2.55 |
| Shares Outstanding | 68.7M | 55.1M | 37.5M | 22.4M | 12.7M |
| Gross Margin | - | - | 82.4% | 88.2% | 73.7% |
| Operating Margin | -16304.8% | -91285.2% | -2300.1% | -2057.5% | -2958.9% |
| Profit Margin | -15345.1% | -118713.1% | -1747.3% | -1769.0% | -2722.1% |